OneMedNet Q1 Revenue Plunges 30% to $96K, Net Loss Widens to $2.45M Amid Bitcoin Funding Push
ONMD has more than doubled off its 52-week low of $0.31 on light trading volume (0.1× avg).
Summary
OneMedNet Corp reported a significant financial downturn for Q1 2026, with revenue plummeting 30% year-over-year to $96K and net loss widening to $2.45 million. This performance sharply contrasts with the 111% revenue growth reported for the full fiscal year 2025. The company, which previously disclosed substantial doubt about its ability to continue as a going concern, is now actively pursuing fundraising and treasury actions, including an unconventional Bitcoin strategy, to fund operations. The substantial revenue decline and increased losses signal deteriorating financial health and heighten concerns about the company's long-term viability. Traders should monitor the success of its fundraising efforts and the execution of its high-risk Bitcoin strategy as key determinants of future operational stability.
At the time of this announcement, ONMD was trading at $0.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $46.2M. The 52-week trading range was $0.31 to $4.22. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.